Dr. Taplin, Leader in Novel Targeted Therapy Development
March 30, 2017 | Press Releases
The Prostate Cancer Foundation (PCF) highlights the accomplishments of PCCTC investigator Dr. Mary-Ellen Taplin of the Dana-Farber Cancer Institute.
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.